Friedreich ataxia, so-called, with optic atrophy and sensorineural deafness

MONDO:0007633

Also known as:

Genes

–

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Companies Active in Friedreich ataxia, so-called, with optic atrophy and sensorineural deafness

0 approved

Organizations with approved therapies for this disease

No approved therapies yet

Research is ongoing — 1 company has orphan drug designations for this disease

Biogen U.S. Corporation

Other

Designated

View all companies active in Friedreich ataxia, so-called, with optic atrophy and sensorineural deafness

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases

Friedreich ataxia, so-called, with optic atrophy and sensorineural deafness

Patient-Friendly Information

Companies Active in Friedreich ataxia, so-called, with optic atrophy and sensorineural deafness

Need this data in your product?

Scientific Intelligence